Search

everythinglearnresearchcommunity

for

Search:↓

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Procyanidin oligomers can protect hair from oxidative damage and could be good for hair care products.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

A small molecule can strengthen fine hair, making it more resistant and natural-feeling.

Taxifolin-based treatments help skin heal after chemical burns.

Using laccase to add poly(tyrosine) to wool makes it less likely to shrink and stronger.

Minoxidil mixed with β-cyclodextrin improves solubility and gradual release.

Extracts from Cercidiphyllum japonicum wood can stimulate mouse hair cell growth like common hair growth treatments.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Chitin and chitosan are useful in cosmetics for oral care, haircare, and skincare, including UV protection and strength improvement.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

The genus Sophora has compounds with potential health benefits and could lead to new drugs, but more research is needed to understand their effects and safety.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.